U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with B

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
183019 Q3 2022 BENZYL ALCOHOL INTRAMUSCULAR INJECTION, SUSPENSION 0.92 %w/v MDE Replacement
183020 Q4 2022 BENZYL ALCOHOL INTRAMUSCULAR INJECTION, SUSPENSION 40mg MDE Replacement
183021 Q3 2022 BENZYL ALCOHOL SOFT TISSUE INJECTION, SUSPENSION 0.92 %w/v MDE Replacement
183022 Q4 2022 BENZYL ALCOHOL SOFT TISSUE INJECTION, SUSPENSION 40mg MDE Replacement
183023 Q3 2022 BENZYL ALCOHOL SUBCONJUNCTIVAL INJECTION 0.95 %w/v MDE Replacement
183024 Q4 2022 BENZYL ALCOHOL SUBCONJUNCTIVAL INJECTION 252mg MDE Replacement
183025 Q3 2022 BUTYLATED HYDROXYANISOLE TOPICAL GEL 0.05 %w/w MDE Replacement
183026 Q4 2022 BUTYLATED HYDROXYANISOLE TOPICAL GEL 3mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: October 1, 2022
Database Last Updated: October 19, 2022

Back to Top